HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip A S Lowden Selected Research

PGL-135

1/2006Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip A S Lowden Research Topics

Disease

4Huntington Disease (Huntington's Disease)
06/2011 - 02/2003
3Nervous System Diseases (Neurological Disorders)
01/2006 - 02/2003
1Neoplasms (Cancer)
08/2003
1Dementia (Dementias)
08/2003

Drug/Important Bio-Agent (IBA)

1Sirtuin 2IBA
06/2011
1CholesterolIBA
06/2011
1benzothiazoleIBA
01/2006
1PGL-135IBA
01/2006
1RiluzoleFDA LinkGeneric
01/2006
1Doxycycline (Periostat)FDA LinkGeneric
08/2003
1Minocycline (Cyclops)FDA LinkGeneric
08/2003
1VorinostatFDA Link
02/2003
1Histone Deacetylase InhibitorsIBA
02/2003
1polyglutamineIBA
02/2003

Therapy/Procedure

4Therapeutics
01/2006 - 02/2003